BriaCell Therapeutics Corp.
BCTX
$4.35
-$0.06-1.36%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 75.68% | 1,972.42% | 1,231.66% | -19.71% | -57.55% |
| Total Receivables | -51.69% | -- | 15,195.39% | 7,039.20% | 11,240.19% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 0.24% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 38.07% | 445.35% | 167.36% | -39.00% | -55.35% |
|
|
|||||
| Total Current Assets | 38.07% | 445.35% | 167.36% | -39.00% | -55.35% |
| Net Property, Plant & Equipment | -24.99% | -23.54% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -7.81% | -7.66% | -7.51% | -7.33% | -7.24% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -40.80% | -40.80% | -- | -- | -- |
| Total Assets | 25.55% | 268.67% | 174.08% | -23.44% | -44.07% |
|
|
|||||
| Total Accounts Payable | -49.72% | -54.21% | -48.94% | 34.80% | 875.80% |
| Total Accrued Expenses | 57.53% | 139.08% | 213.48% | 6.90% | 23.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -33.49% | -46.68% | -35.92% | 33.29% | 376.69% |
|
|
|||||
| Total Current Liabilities | -33.49% | -46.68% | -35.92% | 33.29% | 376.69% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -76.24% | -69.19% | -87.14% | -94.55% | -88.62% |
| Total Liabilities | -44.42% | -49.57% | -59.31% | -70.14% | -58.38% |
|
|
|||||
| Common Stock & APIC | 24.01% | 40.98% | 35.11% | 22.79% | 5.84% |
| Retained Earnings | -31.46% | -30.79% | -23.07% | -13.49% | -22.23% |
| Treasury Stock & Other | 112.80% | 156.05% | 154.33% | 89.47% | 9,651.41% |
| Total Common Equity | 146.82% | 850.54% | 308.13% | 144.63% | 48.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 146.82% | 850.54% | 308.13% | 144.63% | 48.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -90.41% | -80.76% | -76.97% | -53.85% | -60.70% |
| Total Equity | 151.83% | 745.61% | 291.58% | 138.80% | 47.56% |
|
|
|||||